EPISODE · Dec 11, 2024 · 13 MIN
2001: Q&A with Renalytix Executive Chairman, Julian Baines
from The Vox Markets Podcast · host Vox Markets Podcast
Watch on YouTubeRenalytix #RENX, specialises in AI-powered diagnostics for kidney disease. Executive Chairman Julian Baines, in an interview with Vox Markets, highlighted the company's FDA-approved test, KidneyIntelX, which predicts end-stage renal disease risk in diabetic patients, improving outcomes and reducing healthcare costs.
NOW PLAYING
2001: Q&A with Renalytix Executive Chairman, Julian Baines
0:00
13:23
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Vox Markets Podcast?
This episode is 13 minutes long.
When was this The Vox Markets Podcast episode published?
This episode was published on December 11, 2024.
What is this episode about?
Watch on YouTubeRenalytix #RENX, specialises in AI-powered diagnostics for kidney disease. Executive Chairman Julian Baines, in an interview with Vox Markets, highlighted the company's FDA-approved test, KidneyIntelX, which predicts end-stage renal...
Can I download this The Vox Markets Podcast episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!